AFT Pharmaceuticals expects to break even this year despite launch delays

Rebecca Howard
Thu, 02 Aug 2018

By Rebecca Howard Aug. 3 (BusinessDesk) - AFT Pharmaceuticals, which makes the Maxigesic painkiller, continues to target reaching breakeven by the end of this financial year regardless of whether it obtains any additional licensing income. In the last financial year to the end of March, its loss narrowed to $12.7 million from $18.4 million, Chair David Flacks told shareholders at the annual general meeting in Auckland today that Maxigesic is now licensed in 125 countries – up from 110 at the end of its 2017 financial year – and the c...

Try us for 10 days free

Each day we publish 10 to 20 originally-reported news stories on New Zealand business and the political economy.

You also get:

Instant alerts based on any keywords you choose.
A custom library of your saved stories.
An industry-leading search engine

After your trial subscriptions cost $24 a month or $249 a year.

If you don’t like our news service, we make it easy to quit with our one-button cancel.

Find out more

Economy

BRIAN GAYNOR: Aluminium smelter reaches use by date

Brian Gaynor | Sat, 11 Jul 2020

The negative market reaction to Rio Tinto’s announcement that it was winding down the Tiwai Point aluminium smelter was overdone, particularly for investors with long-term perspectives. The smelter...

Markets

MARKET CLOSE: NZ shares fall as energy sector sell-off continues

Dan Brunskill | Fri, 10 Jul 2020

New Zealand shares fell as energy stocks declined for a second day following the announcement Rio Tinto’s New Zealand aluminium smelter will close. Chorus led the market lower on the risk of more r...

Finance

Metlifecare and EQT enter new $6 per share takeover agreement

Jenny Ruth | Fri, 10 Jul 2020

Metlifecare said it has entered into a new scheme of arrangement with Swedish company EQT to buy all its shares for $6 each, a dollar less than the earlier deal EQT had repudiated, but only four of th...

The role of private equity in the wake of COVID-19

As local covid-19 restrictions ease, a new business cycle is beginning in New Zealand.

Sponsored: What’s next for the future of the office?

Think everyone is going to keep working from home? No so fast, says Milford Asset Management.